Article
Integrating genomics into prognostic models for AML.
Seminars in hematology - 1 Oct 2014
Sanchez Matias, Levine Ross L, Rampal Raajit
Abstract excerpt
The use of genomic profiling in acute myeloid leukemia (AML) has led to an improved understanding of disease pathogenesis. Genomic profiling has given rise to fundamental observations about the biology of AML and has served to better define clinical outcomes for patients based on somatic mutational status. As additional mutations are identified with a known or postulated role in AML pathogenesis, the challenge...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.